What is PRAX's dilution risk score?

PRAX has a latest available DilutionScore record of 38/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PRAX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PRAX?

DilutionWatch tracks 25 SEC filing types for PRAX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PRAX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PRAX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PRAX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PRAX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PRAX Dilution Risk Score: 38/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

66

💰 Cash Runway

0

📊 Float Risk

15

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for PRAX.

🔔 Track PRAX — Get forecast alerts →

Market Data

Market Cap$9.76B

Shares Outstanding27.92M

Float24.01M

Cash$758.55M

Debt$1.44M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.8% shares (2026Q1 vs prior)

300 institutional holders · 39.17M shares

#1 PERCEPTIVE ADVISORS LLC 4.07M shares

#2 JANUS HENDERSON GROUP PLC 3.54M shares

#3 Orbis Allan Gray Ltd 2.47M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.66M

Days to Cover11.3

% of Float15.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31

4 INSIDER TRANSACTION 2026-02-10

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PRAX Dilution Snapshot

Praxis Precision Medicines, Inc. (PRAX) has a DilutionScore of 38/100, rated Medium dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for PRAX: 4 on 2026-02-10; 4 on 2026-02-10; xbrl on 2020-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

More Research for PRAX

PRAX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.

PRAX — Praxis Precision Medicines, Inc. Dilution Risk Tracker